Midodrine for the treatment of vasovagal syncope (simple FAINT)
Author:
- Julian M. StewartJSJulian M. Stewart
- 1 December 2006
- journal article
- editorial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 149 (6) , 740-742
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- DrugBank: a comprehensive resource for in silico drug discovery and explorationNucleic Acids Research, 2006
- Clinical and Physiological Effects of an Acute α-1 Adrenergic Agonist and a β-1 Adrenergic Antagonist in Chronic Orthostatic IntoleranceCirculation, 2002
- Midodrine prevents orthostatic intolerance associated with simulated spaceflightJournal of Applied Physiology, 2001
- Midodrine Hydrochloride in the Treatment of Vasovagal SyncopePacing and Clinical Electrophysiology, 1999
- MidodrineDrugs & Aging, 1998
- Efficacy of Midodrine vs Placebo in Neurogenic Orthostatic HypotensionJAMA, 1997
- Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophyNeurology, 1996
- Neurogenic orthostatic hypotension: A double-blind, placebo-controlled study with midodrineThe American Journal of Medicine, 1993
- Mechanisms contributing to the arrhythmogenic influences of Alpha1-adrenergic stimulation in the ischemic heartThe American Journal of Medicine, 1989
- Regulation of coronary resistance vessels and large coronary arteriesThe American Journal of Cardiology, 1985